Immuno-Biological Laboratories Co., Ltd. (TYO:4570)

TYO:4570 Revenue

Immuno-Biological Laboratories had revenue of 286.00M JPY in the quarter ending June 30, 2026, with 35.55% growth. This brings the company's revenue in the last twelve months to 1.08B, up 13.46% year-over-year. In the fiscal year ending March 31, 2026, Immuno-Biological Laboratories had annual revenue of 1.00B with 3.61% growth.

• Revenue (ttm): 1.08B
• Revenue Growth: +13.46%
• P/S Ratio: 10.03
• Revenue / Employee: 19.98M
• Employees: 54
• Market Cap: 10.82B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.00B	35.00M	3.61%
Mar 31, 2025	969.00M	153.00M	18.75%
Mar 31, 2024	816.00M	22.00M	2.77%
Mar 31, 2023	794.00M	147.00M	22.72%
Mar 31, 2022	647.00M	45.00M	7.48%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 13, 2026

Data Sources Report a data error